# A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers

> **NCT00404274** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 97 (actual)

## Conditions studied

- Nausea and Vomiting, Chemotherapy-Induced

## Interventions

- **DRUG:** Casopitant (GW679769) oral tablets
- **DRUG:** Warfarin oral tablets

## Key facts

- **NCT ID:** NCT00404274
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11-01
- **Primary completion:** 2007-03-18
- **Final completion:** 2007-03-18
- **Target enrollment:** 97 (ACTUAL)
- **Last updated:** 2017-08-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00404274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00404274, "A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00404274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*